Washington, DC, December 10, 2007 -- The U.S.-India Business Council (USIBC) is pleased to announce the appointment of Tejpreet Singh Chopra, President and Chief Executive Officer of GE India, to its Board of Directors.
The U.S.-India Business Council is the premier business advocacy organization representing 260 of the largest U.S. companies investing in India, joined by two dozen of India's largest global companies. USIBC's mandate is to strengthen U.S.-India commercial ties.
New Delhi, November 15, 2007 -- GE Energy Financial Services, a unit of GE (NYSE: GE), is reinforcing its foothold in India's power market through KSK Power Venture Plc -- a leading power project developer in India. GE has acquired approximately 26% of the equity in Sayi Power Energy Limited, KSK's majority owner.
Additional financial details of the transaction were not disclosed.
*GE is expanding MIC and imaging product portfolio to achieve $800M revenue by 2010
*Designed and developed "in India for India" and markets worldwide
*Aims to bring technology on par with developed countries
*Early detection and treatment of jaundice in newborns can help counteract the increasing newborn mortality rate in India
*Expands GE's Maternal-Infant Care (MIC) product portfolio with launch of Lullaby™
*Targets $30M market in India plus exports
Bangalore 29 October, 2007 --- General Electric's largest multi-disciplinary center outside of the US, The John F. Welch Technology Center (JFWTC), has announced the appointment of Rajagopalan (Raj) Raghavan as its Human Resources Leader.
In his new role as HR leader for GE-JFWTC, Raj will be responsible for all aspects of Human Resources and Communications for the center.
Invests US$ 22 million in Oriental Structural Engineers Private Limited
New Delhi, October 4, 2007 --- GE Commercial Finance today announced that it has invested US$22 Million in Oriental Structural Engineers Private Limited (OSE), one of India's leading infrastructure construction companies.
Collaboration focused on developing diagnostic tools to predict patients' response to targeted therapies
India -- October 3, 2007 --- GE Global Research, the General Electric Company's (NYSE: GE) centralized research and development organization, and GE Healthcare today announced a three-year collaborative research agreement with Eli Lilly and Company (NYSE: LLY) to discover and develop advanced in vitro diagnostic assays that may predict cancer treatment response to targeted therapies.
*Exclusive agreement with Phoenix Medical Systems
*Exclusive distribution agreement with SLE, UK.
*Agreements aim at broadening capabilities in growing Maternal Infant Care (MIC) segment
*GE Healthcare to produce 15,000 units and turnover USD 30 Million by 2010 for MIC products in India
